Package 46708-326-30

{"route": ["ORAL"], "spl_id": "3b7b2b3c-507c-4ea9-a45d-f5e38f9e1b80", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "upc": ["0346708326302", "0346708325305"], "unii": ["V8G4MOF2V9"], "rxcui": ["597768", "597770", "597772"], "spl_set_id": ["8c8b84f3-6887-4485-b5e0-03f254b88a15"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (46708-326-30)", "package_ndc": "46708-326-30", "marketing_start_date": "20191121"}], "brand_name": "Deferasirox", "product_id": "46708-326_3b7b2b3c-507c-4ea9-a45d-f5e38f9e1b80", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "46708-326", "generic_name": "Deferasirox", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferasirox", "active_ingredients": [{"name": "DEFERASIROX", "strength": "500 mg/1"}], "application_number": "ANDA210060", "marketing_category": "ANDA", "marketing_start_date": "20191121", "listing_expiration_date": "20261231"}